U.S. ATP Assays Market Size Worth USD 1.54 Billion by 2034 | CAGR: 3.60%

The U.S. ATP Assays market size is expected to reach USD 1.54 billion by 2034, according to a new study by Polaris Market Research. The report “U.S. ATP Assays Market Share, Size, Trends, Industry Analysis Report By Type [Luminometric ATP Assays, Enzymatic ATP Assays, Bioluminescence Resonance Energy Transfer (BRET) ATP Assays, Cell-based ATP Assays, Others], By Application, By End Use; Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Adenosine triphosphate (ATP) assays are biochemical tests used to measure ATP levels in biological samples. ATP, the primary energy carrier of cells, is present in all living organisms, making its detection a reliable marker for cell health and proliferation. ATP assays are widely used in microbiology for testing microbial contamination, in cell biology to assess cytotoxicity and drug efficacy, and in environmental monitoring to evaluate the cleanliness of water or surfaces. Industries such as pharmaceuticals, food safety, and healthcare rely on ATP assays for quality control, sterility testing, and hygiene monitoring. The speed, accuracy, and versatility of ATP assays make them essential in research and industrial applications where real-time assessment of cellular activity is crucial.

Do you have any questions? Would you like to request a sample or make an inquiry before purchasing this report? Simply click the link below: https://www.polarismarketresearch.com/industry-analysis/us-atp-assays-market/request-for-sample

In the U.S., ATP assays are widely used across healthcare, biotechnology, and industrial sectors, adhering to stringent regulatory standards established by agencies such as the FDA and EPA. The U.S. market for ATP assays is driven by advancements in bioluminescence technology and increasing demand for rapid microbial detection in food safety, pharmaceuticals, and clinical diagnostics. Companies such as Promega, Thermo Fisher Scientific, and Merck dominate the market, offering high-throughput and portable ATP detection systems. The U.S. emphasizes ATP testing in hospital hygiene to prevent infections, in water treatment facilities for microbial monitoring, and in drug development for cytotoxicity screening. Additionally, the Environmental Protection Agency (EPA) employs ATP assays to assess drinking water quality. The growing focus on automation and miniaturization in diagnostic tools further propels the adoption of ATP assays in the U.S.

Top of FormU.S. ATP Assays Market Report Highlights

• In terms of type, the luminometric ATP assays segment held the largest U.S. ATP assays market share in 2024 due to its high sensitivity, rapid results, and widespread adoption in research and diagnostic applications.
• The cell-based ATP assays segment is projected to grow at a robust pace in the coming years, owing to the rising focus on cell viability and cytotoxicity studies in drug development and cancer research.
• Based on application, the drug discovery and development segment dominated the revenue share in 2024 due to increasing demand for high-throughput screening and the growing emphasis on precision medicine.
• In terms of end use, the pharmaceutical and biotechnology companies segment accounted for a major market share in 2024 due to their extensive use of adenosine triphosphate (ATP) assays in drug discovery, preclinical development, and quality control processes.
• A few key players in the U.S. ATP assays market include Abcam plc; Becton, Dickinson and Company (BD); Biomerieux SA; Merck KGaA; Lonza Group Ltd.; PerkinElmer Inc.; Promega Corporation; Quest Diagnostics Incorporated; and Thermo Fisher Scientific.

Polaris Market Research has segmented the U.S. ATP assays market report on the basis of type, application, and end use:

By Type Outlook (Revenue, USD Billion, 2020–2034)

• Luminometric ATP Assays
• Enzymatic ATP Assays
• Bioluminescence Resonance Energy Transfer (BRET) ATP Assays
• Cell-based ATP Assays
• Others

By Application Mode Outlook (Revenue, USD Billion, 2020–2034)

• Drug Discovery and Development
• Clinical Diagnostics
• Environmental Testing
• Food Safety and Quality Testing
• Others

By End Use Outlook (Revenue, USD Billion, 2020–2034)

• Pharmaceutical and Biotechnology Companies
• Academic and Research Institutes
• Hospital and Diagnostics Laboratories